TheraRadar
← Back
Data updated: Mar 29, 2026

JOURNEY

Dermatology
Specialty

JOURNEY is a specialty pharmaceutical company focused on Dermatology. Key products include QBREXZA.

1949
Since
7
Drugs
-
Trials
2
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Dermatology 100%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...